15 May 2019

Pharmac delays decision on funding life-prolonging drugs

From Checkpoint, 5:38 pm on 15 May 2019

A long-time advocate for breast cancer patients has died, as Pharmac's drug advisory panel again delays its decision on funding life-prolonging cancer treatments Kadcyla and Ibrance. Alex Perrottet reports.